Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.

OBJECTIVE: To elucidate the effect of treatment timing on procedural clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH) for patients treated by endosaccular coil embolization. METHODS: A group of 327 patients who were consecutively treated, during a 46-month period, for ruptured intrac...

Celý popis

Podrobná bibliografie
Hlavní autoři: Baltsavias, G, Byrne, J, Halsey, J, Coley, S, Sohn, M, Molyneux, A
Médium: Journal article
Jazyk:English
Vydáno: 2000
_version_ 1826290568636923904
author Baltsavias, G
Byrne, J
Halsey, J
Coley, S
Sohn, M
Molyneux, A
author_facet Baltsavias, G
Byrne, J
Halsey, J
Coley, S
Sohn, M
Molyneux, A
author_sort Baltsavias, G
collection OXFORD
description OBJECTIVE: To elucidate the effect of treatment timing on procedural clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH) for patients treated by endosaccular coil embolization. METHODS: A group of 327 patients who were consecutively treated, during a 46-month period, for ruptured intracranial aneurysms by coil embolization within 30 days after SAH were evaluated. Outcomes were assessed by comparing immediate pretreatment World Federation of Neurological Surgeons (WFNS) grades, 72-hour posttreatment WFNS grades, and modified Glasgow Outcome Scale scores at 6 months for patients treated within 48 hours (Group 1), 3 to 10 days (Group 2), or 11 to 30 days (Group 3) after SAH. RESULTS: The three interval-to-treatment groups included 33, 38, and 29% of the patients, respectively. Before treatment, 70% of the patients in Group 1, 78% of those in Group 2, and 83% of those in Group 3 were in good clinical grades (i.e., WFNS Grade 1 or 2). After coil embolization, the WFNS grades were either unchanged or improved for 93.5% of the patients in Group 1, 89.5% of those in Group 2, and 91.5% of those in Group 3. After 6 months, 81.3% of the patients in Group 1 experienced good outcomes (modified Glasgow Outcome Scale scores of 1 or 2), as did 84% of those in Group 2 and 80% of those in Group 3. No statistical difference was demonstrated between the three groups when they were compared for these two variables. CONCLUSION: The interval between endovascular treatment and SAH did not affect periprocedural morbidity rates or 6-month outcomes. Coil embolization should therefore be performed as early as possible after aneurysmal SAH, to prevent aneurysmal rerupture.
first_indexed 2024-03-07T02:46:11Z
format Journal article
id oxford-uuid:ac26f9ca-28eb-4126-bcb4-509653c52b23
institution University of Oxford
language English
last_indexed 2024-03-07T02:46:11Z
publishDate 2000
record_format dspace
spelling oxford-uuid:ac26f9ca-28eb-4126-bcb4-509653c52b232022-03-27T03:26:41ZEffects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ac26f9ca-28eb-4126-bcb4-509653c52b23EnglishSymplectic Elements at Oxford2000Baltsavias, GByrne, JHalsey, JColey, SSohn, MMolyneux, AOBJECTIVE: To elucidate the effect of treatment timing on procedural clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH) for patients treated by endosaccular coil embolization. METHODS: A group of 327 patients who were consecutively treated, during a 46-month period, for ruptured intracranial aneurysms by coil embolization within 30 days after SAH were evaluated. Outcomes were assessed by comparing immediate pretreatment World Federation of Neurological Surgeons (WFNS) grades, 72-hour posttreatment WFNS grades, and modified Glasgow Outcome Scale scores at 6 months for patients treated within 48 hours (Group 1), 3 to 10 days (Group 2), or 11 to 30 days (Group 3) after SAH. RESULTS: The three interval-to-treatment groups included 33, 38, and 29% of the patients, respectively. Before treatment, 70% of the patients in Group 1, 78% of those in Group 2, and 83% of those in Group 3 were in good clinical grades (i.e., WFNS Grade 1 or 2). After coil embolization, the WFNS grades were either unchanged or improved for 93.5% of the patients in Group 1, 89.5% of those in Group 2, and 91.5% of those in Group 3. After 6 months, 81.3% of the patients in Group 1 experienced good outcomes (modified Glasgow Outcome Scale scores of 1 or 2), as did 84% of those in Group 2 and 80% of those in Group 3. No statistical difference was demonstrated between the three groups when they were compared for these two variables. CONCLUSION: The interval between endovascular treatment and SAH did not affect periprocedural morbidity rates or 6-month outcomes. Coil embolization should therefore be performed as early as possible after aneurysmal SAH, to prevent aneurysmal rerupture.
spellingShingle Baltsavias, G
Byrne, J
Halsey, J
Coley, S
Sohn, M
Molyneux, A
Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.
title Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.
title_full Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.
title_fullStr Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.
title_full_unstemmed Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.
title_short Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.
title_sort effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes
work_keys_str_mv AT baltsaviasg effectsoftimingofcoilembolizationafteraneurysmalsubarachnoidhemorrhageonproceduralmorbidityandoutcomes
AT byrnej effectsoftimingofcoilembolizationafteraneurysmalsubarachnoidhemorrhageonproceduralmorbidityandoutcomes
AT halseyj effectsoftimingofcoilembolizationafteraneurysmalsubarachnoidhemorrhageonproceduralmorbidityandoutcomes
AT coleys effectsoftimingofcoilembolizationafteraneurysmalsubarachnoidhemorrhageonproceduralmorbidityandoutcomes
AT sohnm effectsoftimingofcoilembolizationafteraneurysmalsubarachnoidhemorrhageonproceduralmorbidityandoutcomes
AT molyneuxa effectsoftimingofcoilembolizationafteraneurysmalsubarachnoidhemorrhageonproceduralmorbidityandoutcomes